IPSEN – Buy-back programme – Art 5 of MAR – Week 26 – 2023
- 04 July 2023 - 1 mins read
Aggregated presentation by day and by market
| Name of issuer | Identification code of issuer (Legal Entity Identifier) | Day of transaction | Identification code of financial instrument | Aggregated daily volume (in number of shares) | Daily weighted average price of the purchased shares * | Market (MIC Code) |
| IPSEN | 549300M6SGDPB4Z94P11 | 26/06/2023 | FR0010259150 | 1,272 | 108.60 | AQEU |
| IPSEN | 549300M6SGDPB4Z94P11 | 26/06/2023 | FR0010259150 | 1,123 | 108.28 | CEUX |
| IPSEN | 549300M6SGDPB4Z94P11 | 26/06/2023 | FR0010259150 | 553 | 108.41 | TQEX |
| IPSEN | 549300M6SGDPB4Z94P11 | 26/06/2023 | FR0010259150 | 6,252 | 108.38 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 27/06/2023 | FR0010259150 | 1,284 | 104.29 | AQEU |
| IPSEN | 549300M6SGDPB4Z94P11 | 27/06/2023 | FR0010259150 | 1,443 | 104.41 | CEUX |
| IPSEN | 549300M6SGDPB4Z94P11 | 27/06/2023 | FR0010259150 | 718 | 104.59 | TQEX |
| IPSEN | 549300M6SGDPB4Z94P11 | 27/06/2023 | FR0010259150 | 5,755 | 104.40 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 28/06/2023 | FR0010259150 | 1,218 | 105.63 | AQEU |
| IPSEN | 549300M6SGDPB4Z94P11 | 28/06/2023 | FR0010259150 | 2,939 | 105.56 | CEUX |
| IPSEN | 549300M6SGDPB4Z94P11 | 28/06/2023 | FR0010259150 | 354 | 105.17 | TQEX |
| IPSEN | 549300M6SGDPB4Z94P11 | 28/06/2023 | FR0010259150 | 4,432 | 105.41 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 29/06/2023 | FR0010259150 | 223 | 110.01 | AQEU |
| IPSEN | 549300M6SGDPB4Z94P11 | 29/06/2023 | FR0010259150 | 50 | 110.00 | TQEX |
| IPSEN | 549300M6SGDPB4Z94P11 | 29/06/2023 | FR0010259150 | 1,727 | 110.38 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 30/06/2023 | FR0010259150 | 79 | 111.20 | AQEU |
| IPSEN | 549300M6SGDPB4Z94P11 | 30/06/2023 | FR0010259150 | 34 | 111.20 | CEUX |
| IPSEN | 549300M6SGDPB4Z94P11 | 30/06/2023 | FR0010259150 | 1,787 | 110.83 | XPAR |
| * Two-digit rounding after the decimal | TOTAL | 31,243 | 106.66 | |||
Attachment
07 May 2024
5 mins read
Ipsen S.A. – Formalities for making available and consulting preparatory documents to the 2024 Annual General Meeting
06 May 2024
1 mins read
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
24 April 2024
7 mins read
Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance
22 April 2024
5 mins read
Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases
17 April 2024
4 mins read
Ipsen publishes its 2023 Universal Registration Document
08 April 2024
1 mins read
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
02 April 2024
7 mins read
Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors
07 March 2024
1 mins read
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
15 February 2024
1 mins read
Ipsen S.A. publishes its 2023 Consolidated Financial Statements
13 February 2024
14 mins read